Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Cepheid; Enigma Diagnostics

NEW YORK (GenomeWeb News) – Cepheid said this week that it released an improved Xpert BCR-ABL Monitor test as a CE IVD product in the European Union. The firm said that the new test, which is used to monitor patients with chronic myelogenous leukemia, detects BCR-ABL chromosomal translocation in about 2 hours as compared to 2.5 hours for the original product release.

Enigma Diagnostics disclosed this week that the European Patent Office recently rejected a claim from Becton Dickinson in opposition to a patent filed by the firm. The Porton Down, England-based molecular diagnostics startup also said that the European Patent Office issued it a patent for the use of endonuclease-based reporting in PCR and other nucleic acid amplification technologies, which was at the center of the dispute with BD.

Enigma is developing a fully automated molecular diagnostics system for point-of-care testing.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.